These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 17453955

  • 1. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
    Ermis SS, Cetinkaya Z, Kiyici H, Inan UU, Ozturk F.
    Curr Eye Res; 2007 Apr; 32(4):337-44. PubMed ID: 17453955
    [Abstract] [Full Text] [Related]

  • 2. Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone.
    Sakalar YB, Ozekinci S, Celen MK.
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):593-8. PubMed ID: 21834669
    [Abstract] [Full Text] [Related]

  • 3. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
    Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ.
    Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
    Kim JY, Kim SY.
    Invest Ophthalmol Vis Sci; 2011 Mar 25; 52(3):1742-7. PubMed ID: 21169530
    [Abstract] [Full Text] [Related]

  • 5. Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis.
    De Kaspar HM, Ta CN, Engelbert M, Mette M, Thiel M, Kampik A.
    Retina; 2008 Feb 25; 28(2):326-32. PubMed ID: 18301039
    [Abstract] [Full Text] [Related]

  • 6. Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
    Ferrer C, Rodríguez A, Abad JL, Fernandez J, Alió JL.
    Br J Ophthalmol; 2008 May 25; 92(5):678-82. PubMed ID: 18211926
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of intravitreal administrations of linezolid in an experimental model of S. aureus-related endophthalmitis.
    Saleh M, Lefèvre S, Acar N, Bourcier T, Marcellin L, Prévost G, Subilia A, Gaucher D, Jehl F.
    Invest Ophthalmol Vis Sci; 2012 Jul 20; 53(8):4832-41. PubMed ID: 22661478
    [Abstract] [Full Text] [Related]

  • 8. Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model.
    Ermis SS, Cetinkaya Z, Kiyici H, Ozturk F.
    Tohoku J Exp Med; 2005 Mar 20; 205(3):223-9. PubMed ID: 15718814
    [Abstract] [Full Text] [Related]

  • 9. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
    Deren YT, Ozdek S, Kalkanci A, Akyürek N, Hasanreisoğlu B.
    Can J Microbiol; 2010 Jan 20; 56(1):1-7. PubMed ID: 20130687
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of intravitreal piperacillin/tazobactam in rabbits with experimental Staphylococcus epidermidis endophthalmitis: a comparison with vancomycin.
    Ozkiriş A, Evereklioglu C, Eşel D, Akgün H, Erkiliç K.
    Ophthalmic Res; 2005 Jan 20; 37(3):168-74. PubMed ID: 15942265
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental bacillus cereus endophthalmitis.
    Liu F, Kwok AK, Cheung BM.
    Curr Eye Res; 2008 Sep 20; 33(9):761-8. PubMed ID: 18798079
    [Abstract] [Full Text] [Related]

  • 12. A comparison of intravitreal piperacillin/tazobactam with ceftazidime in experimental Pseudomonas aeruginosa endophthalmitis.
    Ozkiriş A, Evereklioglu C, Akgün H, Eşel D, Caner F, Erkiliç K.
    Exp Eye Res; 2005 Mar 20; 80(3):361-7. PubMed ID: 15721618
    [Abstract] [Full Text] [Related]

  • 13. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model.
    Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ.
    Am J Ophthalmol; 2004 Jul 20; 138(1):33-7. PubMed ID: 15234279
    [Abstract] [Full Text] [Related]

  • 14. Comparison of intravitreal vancomycin and daptomycin application in experimental methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis in rabbits.
    Coskun E, Okumus S, Gurler B, Demir T, Bahar AY, Zer Y, Comez A, Tatar MG, Aksoy U, Erbagci I.
    Cutan Ocul Toxicol; 2013 Sep 20; 32(3):222-7. PubMed ID: 23368969
    [Abstract] [Full Text] [Related]

  • 15. Effect of caffeic acid phenethyl ester on treatment of experimentally induced methicillin-resistant Staphylococcus epidermidis endophthalmitis in a rabbit model.
    Yildirim O, Yilmaz A, Oz O, Vatansever H, Cinel L, Aslan G, Tamer L, Adigüzel U, Arpaci R, Kanik A, Emekdaş G.
    Cell Biochem Funct; 2007 Sep 20; 25(6):693-700. PubMed ID: 16981209
    [Abstract] [Full Text] [Related]

  • 16. Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.
    Hosseini H, Mehryar M, Eghtedari M, Ahmadi F, Nowroozizadeh S.
    Curr Eye Res; 2009 Feb 20; 34(2):145-51. PubMed ID: 19219686
    [Abstract] [Full Text] [Related]

  • 17. Timing of dexamethasone treatment in experimental Staphylococcus aureus endophthalmitis.
    Yoshizumi MO, Lee GC, Equi RA, Kim IT, Pitchekian-Halabi H, Adamu SA, Mondino BJ.
    Retina; 1998 Feb 20; 18(2):130-5. PubMed ID: 9564693
    [Abstract] [Full Text] [Related]

  • 18. Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model.
    Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ.
    J Ocul Pharmacol Ther; 2008 Feb 20; 24(1):1-7. PubMed ID: 18370872
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model.
    Deng SX, Penland S, Gupta S, Fiscella R, Edward DP, Tessler HH, Goldstein DA.
    Invest Ophthalmol Vis Sci; 2006 Apr 20; 47(4):1516-21. PubMed ID: 16565387
    [Abstract] [Full Text] [Related]

  • 20. Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.
    Skiadas I, Pefanis A, Papalois A, Kyroudi A, Triantafyllidi H, Tsaganos T, Giamarellou H.
    Antimicrob Agents Chemother; 2007 Aug 20; 51(8):2848-54. PubMed ID: 17562794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.